The Galunisertib Scan Dash Panel Widget

High incidence of early post-transplant complications such as acute rejection has been observed. A multicenter study including HIV-infected patients who underwent KT in Spain, from 2001 to 2011, was performed. The study population included 108 recipients, 36 HIV-infected, and 72 matched HIV-negative KT recipients. HIV-infected recipients developed more delayed graft function (DGF) (52% vs. 21%, P? http://www.selleck.cn/products/BIBW2992.html levels were very high in the first week and significantly lower in the second week post-transplant (P?=?0.042). Post-transplant ART was significantly changed: protease inhibitors use decreased (P?=?0.034) and integrase inhibitor use increased (P? http://www.selleckchem.com/products/z-vad-fmk.html recipients that can affect graft survival. Strategies to prevent DGF and antiretroviral regimes with less drug interactions could improve outcomes. Human immunodeficiency virus (HIV) infection has ceased to be a contraindication in solid-organ transplant. In the last decade, numerous studies have shown that kidney transplantation (KT) is safe and does not worsen evolution of the HIV infection [1-9]. However, experience is still scarce, especially in Europe [4, 6, 7]. The Spanish Group for Advancement in Transplantation http://www.selleckchem.com/products/ly2157299.html (GREAT group) includes 21 Spanish hospitals that perform KT. In 2008, we set up a multicenter study to analyze the outcomes of KT in HIV-infected patients compared to HIV-negative KT patients (TRASRENVIH study). We reported a first analysis including HIV-infected KT recipients until 2009, and the current study is its continuation [6]. A higher incidence of acute rejection in the early post-transplant period has been noticed in the largest series of HIV-infected KT recipients, and some studies also describe a high incidence of delayed graft function (DGF) [1-3, 6, 8, 9]. Both factors can affect graft survival [2, 3, 10, 11]. However, the high frequency of DGF has not been previously highlighted. Also, the evolution of immunosuppressive and antiretroviral therapy (ART) is poorly known especially in the first weeks after transplantation. We have focused our analysis on these issues not examined until now and which may affect graft survival. This is a multicenter, retrospective cohort study including HIV-infected patients who underwent KT in Spain in the era of the combined ART (cART), from January 2001 to December 2011.